Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishment and Clinical Application of Risk Classification Model Based on Molecular Typing of Medulloblastoma in Children

NCT05406947 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT05406947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05406947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishment and Clinical Application of Risk Classification Model Based on Molecular Typing of Medulloblastoma in Children
Lead sponsor
Beijing Tiantan Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
January 30, 2023
Completion date
December 31, 2030
Enrollment
350 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

medulloblastoma, childhood